Xeris Biopharma Holdings Cash from Operations (TTM) Insights

Xeris Biopharma Holdings Inc (XERS)

2.87 +0.05 (+1.77%) USD | NASDAQ | Sep 27, 16:00

2.87 0.00 (0.00%) After-Hours: 19:04

Cash from Operations (TTM) Chart

Historical Cash from Operations (TTM) Data

View and export this data back to 2017. Upgrade now.

Date	Value
June 30, 2024	-37.79M
March 31, 2024	-41.19M
December 31, 2023	-47.02M
September 30, 2023	-70.61M
June 30, 2023	-73.76M
March 31, 2023	-80.62M
December 31, 2022	-102.89M
September 30, 2022	-115.72M
June 30, 2022	-120.58M
March 31, 2022	-119.99M
December 31, 2021	-95.54M
September 30, 2021	-77.46M
June 30, 2021	-71.83M
March 31, 2021	-75.57M

Date	Value
December 31, 2020	-80.56M
September 30, 2020	-99.26M
June 30, 2020	-112.86M
March 31, 2020	-112.14M
December 31, 2019	-104.35M
September 30, 2019	-93.11M
June 30, 2019	-78.44M
March 31, 2019	-69.63M
December 31, 2018	-56.28M
September 30, 2018	-47.04M
June 30, 2018	-36.70M
March 31, 2018	-28.95M
December 31, 2017	-24.66M

Cash From Operations Definition

Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.

Read full definition.

Cash from Operations (TTM) Range, Past 5 Years

-120.58M

Minimum

Jun 2022

-37.79M

Maximum

Jun 2024

-86.64M

Average

-86.87M

Median

Cash from Operations (TTM) Benchmarks